Eric K Rowinsky insider trades

Open-market stock purchases and sales by Eric K Rowinsky, Director at Biogen Inc, from SEC Form 4 filings since Feb 2, 2010.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +93%.

Recent trades

DateStockTradeValue
Jun 9, 2026BIIB Biogen IncBought (not open market)—
May 21, 2026VSTM Verastem, IncBought (not open market)—

Companies traded

  • BIIB Biogen Inc: 1 buy, 7 sales, last Jun 9, 2026
  • VSTM Verastem, Inc: 1 buy, last May 21, 2026
  • FBIO Fortress Biotech, Inc: 1 buy, 5 sales, last Jan 1, 2024
  • NAVB Navidea Biopharmaceuticals, Inc: other filings, last Feb 20, 2018
  • BIND Dnib Unwind, Inc: other filings, last Aug 29, 2016
  • STML Stemline Therapeutics Inc: 5 sales, last Apr 27, 2015
  • CNDO Coronado Biosciences Inc: other filings, last Mar 12, 2015
  • [CNDO] Coronado Biosciences Inc: other filings, last Feb 20, 2014
  • NEOP Neoprobe Corp: 1 buy, last Aug 19, 2011
  • ANX Adventrx Pharmaceuticals Inc: other filings, last Jun 30, 2010

Get free alerts when Eric K Rowinsky files a new trade →